Benethera
PrivateLast Round
Series A
May 21, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Benethera is a biopharmaceutical company that develops innovative Treg-based small molecule and cell drug products for the treatment of autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Benethera Comparables
Compare Benethera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 83% | |
| Quell Therapeutics | 81% | |
| NImmune Biopharma | 80% | |
Benethera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 21, 2026 | ||||
| Pre Seed | Jul 28, 2023 | ||||
| Angel | Dec 31, 2022 | ||||
| Angel | Dec 15, 2021 |
Benethera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | Pre Seed, Series A |
| Fudan Science and Technology Innovation Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Raised Series A led by Fudan Science and Technology Innovation Fund and Lapam Capital.
- Dec 15, 2021
Completed an Angel funding round.
Benethera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Benethera's valuation, stock price, and market status.